To the Nucleate Community, The time has come! I write this open letter with a mix of emotions, and with the official news that following a 6-month training and evaluation period, our Board of Directors unanimously voted to finalize Sammi Sison’s and Michael Retchin’s appointments as the next Co-Presidents of…

Nucleate, the nonprofit organization led by academic trainees and dedicated to empowering the next generation of biotech leaders, today announced its Arizona chapter. Nucleate Arizona is an Associate chapter, serving a new frontier of biotech entrepreneurship education. “We are excited to launch our Arizona chapter, led by an incredible team…

Nucleate, the nonprofit organization led by academic trainees and dedicated to empowering the next generation of biotech leaders, today announced its newest Core and Associate chapters. The Core chapters are Israel, Denmark, Germany, and Florida; the Associate chapters are Singapore, Pittsburgh, Arizona, and the Baltics. A Global Biotechnology Network With the expansion of Nucleate…

Nucleate is proud to announce the launch of DojoGrants, its pilot grant program for individual undergraduate scholars. These undergraduate research grants are part of the latest program from Dojo, Nucleate’s initiative to bring forward educational and logistical support for undergraduates looking to enter the life sciences sector. Hosted in partnership…

Nucleate, a nonprofit organization dedicated to empowering future biotech leaders, is delighted to announce that MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, will be a Platinum sponsor of Nucleate’s 2023 Activator program. Nucleate’s equity-free Activator program has supported…

Nucleate is a nonprofit organization that was started to empower the next generation of biotech leaders. Together with BLUE KNIGHT™, we are excited to share the story of Glyphic Biotechnologies, a protein sequencing company that originated in academia. Tell us more about Glyphic Biotechnologies and the impact you hope to make on patients and the community? Although decoding the human genome through the invention of DNA sequencing has…

Nucleate, the nonprofit organization led by academic trainees and dedicated to empowering future biotech leaders, today announced the renewal of its partnership with Alnylam Pharmaceuticals. Entrepreneurs entering the biotech industry can find it tough to break into, limiting innovation in disease treatment. Nucleate aims to solve this problem by providing…

Nucleate, the nonprofit organization dedicated to empowering the next generation of biotech leaders, announced today the planned co-President transition of Oliver Dodd to Michael Retchin in June 2023. This transition marks a significant milestone for Nucleate as a student-led organization, concluding the first period of co-Presidency transition. Oliver joined Nucleate…

Nucleate, the nonprofit organization dedicated to empowering future biotech leaders, announced 143 venture teams in the first international cycle of its Activator program. Meet the 2023 Activator teams: teams.nucleate.xyz. Participating teams will now refine their scientific discoveries into biotech venture theses and train under Nucleate’s unparalleled network, rigorous curriculum, funded…